ICON Pre-Paid Expenses 2010-2024 | ICLR

ICON pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • ICON pre-paid expenses for the quarter ending September 30, 2024 were $0.141B, a 6.43% decline year-over-year.
  • ICON pre-paid expenses for 2023 were $0.132B, a 3.64% decline from 2022.
  • ICON pre-paid expenses for 2022 were $0.137B, a 19.92% increase from 2021.
  • ICON pre-paid expenses for 2021 were $0.114B, a 113.78% increase from 2020.
ICON Annual Pre-Paid Expenses
(Millions of US $)
2023 $132
2022 $137
2021 $114
2020 $53
2019 $42
2018 $37
2017 $34
2016 $35
2015 $36
2014 $28
2013 $25
2012 $
2011 $
2010 $
2009 $
ICON Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $141
2024-06-30 $139
2024-03-31 $149
2023-12-31 $132
2023-09-30 $150
2023-06-30 $153
2023-03-31 $170
2022-12-31 $137
2022-09-30 $129
2022-06-30 $131
2022-03-31 $151
2021-12-31 $114
2021-09-30 $132
2021-06-30 $71
2021-03-31 $87
2020-12-31 $53
2020-09-30 $43
2020-06-30 $38
2020-03-31 $42
2019-12-31 $42
2019-09-30 $43
2019-06-30 $41
2019-03-31 $40
2018-12-31 $37
2018-09-30 $42
2018-06-30 $24
2018-03-31 $46
2017-12-31 $34
2017-09-30 $42
2017-06-30 $39
2017-03-31 $38
2016-12-31 $35
2016-09-30 $39
2016-06-30 $37
2016-03-31 $35
2015-12-31 $36
2015-09-30 $40
2015-06-30
2015-03-31
2014-12-31 $28
2014-09-30
2014-06-30
2014-03-31
2013-12-31 $25
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Services $17.552B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.604B 11.61
Cencora (COR) United States $48.412B 17.85
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $22.359B 0.00
Viatris (VTRS) United States $15.815B 4.87
Avantor (AVTR) United States $13.857B 20.78
Revvity (RVTY) United States $13.522B 23.49
CochLear (CHEOY) Australia $12.586B 0.00
BioMerieux (BMXMF) France $12.119B 0.00
Solventum (SOLV) United States $12.029B 0.00
Medpace Holdings (MEDP) United States $10.624B 29.93
Charles River Laboratories (CRL) United States $9.930B 19.19
HealthEquity (HQY) United States $9.139B 49.60
Doximity (DOCS) United States $8.961B 52.75
Sonic Healthcare (SKHHY) Australia $8.813B 0.00
Bausch + Lomb (BLCO) Canada $6.977B 32.47
Life Times (LTH) United States $5.046B 33.40
Organon (OGN) United States $3.835B 3.87
Sotera Health (SHC) United States $3.515B 18.80
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.968B 33.84
Concentras Parent (CON) United States $2.735B 0.00
PACS (PACS) United States $2.522B 0.00
Alignment Healthcare (ALHC) United States $2.320B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.155B 11.21
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GeneDx Holdings (WGS) United States $1.980B 0.00
Teladoc Health (TDOC) United States $1.791B 0.00
GoodRx Holdings (GDRX) United States $1.635B 42.90
Progyny (PGNY) United States $1.275B 25.81
Pediatrix Medical (MD) United States $1.267B 12.40
CareDx (CDNA) United States $1.211B 0.00
Establishment Labs Holdings (ESTA) $1.193B 0.00
AMN Healthcare Services Inc (AMN) United States $0.978B 6.62
Embecta (EMBC) United States $0.808B 5.38
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.733B 0.00
SBC Medicals (SBC) United States $0.670B 0.00
InnovAge Holding (INNV) United States $0.627B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
DocGo (DCGO) United States $0.420B 15.85
Enhabit (EHAB) United States $0.376B 32.48
COMPASS Pathways (CMPS) United Kingdom $0.304B 0.00
ModivCare (MODV) United States $0.250B 13.54
LifeMD (LFMD) United States $0.246B 0.00
Sera Prognostics (SERA) United States $0.206B 0.00
Biodesix (BDSX) United States $0.175B 0.00
Nutex Health (NUTX) United States $0.173B 0.00
Beauty Health (SKIN) United States $0.173B 0.00
MultiPlan (MPLN) United States $0.114B 0.00
Ascend Wellness Holdings (AAWH) United States $0.094B 0.00
So-Young (SY) China $0.093B 17.98
Singular Genomics Systems (OMIC) United States $0.055B 0.00
OncoCyte (OCX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.022B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00